Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial
Authors:
- 11 November 2016
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 28 (1) , 201-209
Abstract
Summary It is unknown whether vitamin D supplementation positively impacts body composition and bone outcomes in children and young adults with HIV. This RCT found that despite increasing 25(OH)D concentrations, high dose vitamin D3 supplementation did not impact bone or body composition in children and young adults with HIV infection. Introduction The objective of this paper was to determine the impact of high-dose daily cholecalciferol (vitamin D3) supplementation on body composition and bone density, structure, and strength in children and young adults with perinatally acquired (PHIV) or behaviorally acquired (BHIV) HIV infection. Methods Participants were randomized to receive vitamin D3 supplementation (7000 IU/day) or placebo for 12 months. Serum 25-hydroxyvitamin D [25(OH)D] concentrations, dual energy X-ray absorptiometry (DXA) of the whole body and lumbar spine, and peripheral quantitative computed tomography (pQCT) of tibia sites were acquired at 0, 6, and 12 months. DXA and pQCT outcomes were expressed as sex- and population-ancestry specific Z-scores relative to age and adjusted for height or tibia length, as appropriate. Results Fifty-eight participants (5.0 to 24.9 years) received vitamin D3 supplements (n = 30) or placebo (n = 28). At enrollment, groups were similar in age, sex, population ancestry, growth status, serum 25(OH)D concentrations, body composition, and size-adjusted bone measures. Median 25(OH)D concentrations were similar (17.3 ng/mL in the vitamin D3 supplementation group vs 15.6 ng/mL in the placebo group), and both groups had mild bone deficits. At 12 months, 25(OH)D rose significantly in the vitamin D supplementation group but not in the placebo group (26.4 vs 14.8 ng/mL, respectively, p < 0.008). After adjusting for population ancestry, sex, antiretroviral therapy use, and season, there were no significant treatment group differences in bone or body composition outcomes. Conclusions Despite increasing 25(OH)D concentrations, 12 months of high-dose vitamin D3 supplementation did not impact bone or body composition in children and young adults with HIV infection.Keywords
Funding Information
- NIH/National Center for Complementary and Alternative Medicine (Grant R01AT005531)
- National Center for Research Resources (UL1RR024134)
- National Center for Advancing Translational Sciences (UL1TR000003)
- University of Pennsylvania Center for AIDS Research (P30AI045008)
This publication has 41 references indexed in Scilit:
- HIV-Associated Lipodystrophy: Impact of Antiretroviral TherapyDrugs, 2013
- Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trialThe American Journal of Clinical Nutrition, 2012
- Antiretroviral therapy and bone mineral measurements in HIV-infected youthsBone, 2010
- Effects of Sex, Race, and Puberty on Cortical Bone and the Functional Muscle Bone Unit in Children, Adolescents, and Young AdultsThe Journal of Clinical Endocrinology & Metabolism, 2010
- Height Adjustment in Assessing Dual Energy X-Ray Absorptiometry Measurements of Bone Mass and Density in ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANESPLOS ONE, 2009
- Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and AdolescentsPediatrics, 2009
- Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strengthBone, 1996
- Smoothing reference centile curves: The lms method and penalized likelihoodStatistics in Medicine, 1992
- Validation of a self-administered instrument to assess stage of adolescent developmentJournal of Youth and Adolescence, 1980